Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 4
2020 7
2021 10
2022 6
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Berinstein JA, Steiner CA, Higgins PDR. Berinstein JA, et al. Clin Gastroenterol Hepatol. 2021 Jun;19(6):1303-1304. doi: 10.1016/j.cgh.2020.08.023. Epub 2020 Nov 26. Clin Gastroenterol Hepatol. 2021. PMID: 33248182 No abstract available.
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study.
Berinstein JA, Sheehan JL, Dias M, Berinstein EM, Steiner CA, Johnson LA, Regal RE, Allen JI, Cushing KC, Stidham RW, Bishu S, Kinnucan JAR, Cohen-Mekelburg SA, Waljee AK, Higgins PDR. Berinstein JA, et al. Clin Gastroenterol Hepatol. 2021 Oct;19(10):2112-2120.e1. doi: 10.1016/j.cgh.2021.05.038. Epub 2021 May 25. Clin Gastroenterol Hepatol. 2021. PMID: 34048936 Free PMC article.
In-hospital management of inflammatory bowel disease.
Berinstein JA, Aintabi D, Higgins PDR. Berinstein JA, et al. Curr Opin Gastroenterol. 2023 Jul 1;39(4):274-286. doi: 10.1097/MOG.0000000000000953. Epub 2023 May 26. Curr Opin Gastroenterol. 2023. PMID: 37265192 Review.
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience.
Berinstein JA, Karl T, Patel A, Dolinger M, Barrett TA, Ahmed W, Click B, Steiner CA, Dulaney D, Levine J, Hassan SA, Perry C, Flomenhoft D, Ungaro RC, Berinstein EM, Sheehan J, Cohen-Mekelburg S, Regal RE, Stidham RW, Bishu S, Colombel JF, Higgins PDR. Berinstein JA, et al. Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002674. Online ahead of print. Am J Gastroenterol. 2024. PMID: 38275248
Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the Literature.
Berinstein EM, Sheehan JL, Jacob J, Steiner CA, Stidham RW, Shannon C, Bishu S, Levine J, Cohen-Mekelburg SA, Waljee AK, Higgins PDR, Berinstein JA. Berinstein EM, et al. Among authors: berinstein ja. Dig Dis Sci. 2023 Jun;68(6):2604-2623. doi: 10.1007/s10620-023-07837-0. Epub 2023 Feb 20. Dig Dis Sci. 2023. PMID: 36807832 Free PMC article.
Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review.
Steiner CA, Berinstein JA, Louissaint J, Higgins PDR, Spence JR, Shannon C, Lu C, Stidham RW, Fletcher JG, Bruining DH, Feagan BG, Jairath V, Baker ME, Bettenworth D, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Steiner CA, et al. Among authors: berinstein ja. Clin Gastroenterol Hepatol. 2022 Apr;20(4):817-846.e10. doi: 10.1016/j.cgh.2021.05.054. Epub 2021 Jun 2. Clin Gastroenterol Hepatol. 2022. PMID: 34089850 Free PMC article.
A Predictive Model to Identify Complicated Clostridiodes difficile Infection.
Berinstein JA, Steiner CA, Rifkin S, Alexander Perry D, Micic D, Shirley D, Higgins PDR, Young VB, Lee A, Rao K. Berinstein JA, et al. Open Forum Infect Dis. 2023 Feb 2;10(2):ofad049. doi: 10.1093/ofid/ofad049. eCollection 2023 Feb. Open Forum Infect Dis. 2023. PMID: 36820317 Free PMC article.
31 results